GlassScriptPhysician profile
Stanley Kupiszewski
NPI 1255324679
$15,217.44
in general payments reported to CMS, 2019-2025
19 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,950 · 2020: $920 · 2021: $294 · 2022: $1,743 · 2023: $670 · 2024: $1,477 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156 · Travel and Lodging: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.59 |
| Travel and Lodging | $1,155.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fx Shoulder Solutions, INC | $7,472.17 | 2019 | |
| Reel Surgical, INC. | $3,142.20 | 2020-2025 | |
| Arthrex, INC. | $2,233.60 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $1,049.83 | 2021-2025 | Persona, Mymobility Platform, Rosa |
| Stryker Corporation | $280.43 | 2020-2024 | Blueprint Patient Specific Instrumentation |
| Smith+Nephew, INC. | $197.03 | 2019-2023 | Spatial Frame |
| Ermi LLC | $158.93 | 2019-2022 | |
| Biocomposites INC | $158.01 | 2019-2021 | |
| Bone Support INC. | $133.14 | 2020 | |
| Wright Medical Technology, INC. | $73.62 | 2019-2020 | |
| Linvatec Corporation | $66.67 | 2022 | |
| Innovation Technologies INC | $59.61 | 2022-2023 | Irrisept |
| Endo Pharmaceuticals INC. | $52.58 | 2019-2023 | Xiaflex |
| Globus Medical, INC. | $29.96 | 2024 | Distal Radius II |
| Endo USA, INC. | $29.63 | 2025 | Xiaflex |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $26.58 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $25.59 | 2019 | |
| Theragen, INC. | $14.29 | 2022 | |
| Pacira Therapeutics, INC. | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Kupiszewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.